Edap Tms (NASDAQ:EDAP) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Edap Tms (NASDAQ:EDAP - Get Free Report) in a research note issued to investors on Sunday. The brokerage set a "hold" rating on the medical equipment provider's stock.

Other analysts have also recently issued reports about the company. HC Wainwright restated a "buy" rating and issued a $19.00 target price on shares of Edap Tms in a report on Friday, March 28th. Jefferies Financial Group reissued a "hold" rating and issued a $2.00 price objective (down previously from $8.00) on shares of Edap Tms in a report on Friday, April 4th. Finally, Piper Sandler decreased their target price on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating on the stock in a report on Friday, March 28th.

Edap Tms Price Performance

Shares of Edap Tms stock traded up $0.04 during trading hours on Friday, reaching $1.35. 6,914 shares of the company's stock were exchanged, compared to its average volume of 93,719. The business has a fifty day moving average of $2.19 and a two-hundred day moving average of $2.36. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $49.94 million, a P/E ratio of -2.07 and a beta of 0.12. Edap Tms has a 1 year low of $1.26 and a 1 year high of $7.73.

Edap Tms (NASDAQ:EDAP - Get Free Report) last released its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.11) by $0.06. The company had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. As a group, research analysts predict that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Edap Tms

Hedge funds have recently modified their holdings of the business. Illumine Investment Management LLC acquired a new position in Edap Tms in the fourth quarter valued at about $50,000. BNP Paribas Financial Markets raised its stake in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider's stock valued at $59,000 after acquiring an additional 4,400 shares during the period. Jane Street Group LLC lifted its holdings in shares of Edap Tms by 174.7% in the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider's stock worth $69,000 after acquiring an additional 73,361 shares during the last quarter. Millennium Management LLC boosted its position in shares of Edap Tms by 218.5% during the 4th quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock worth $108,000 after purchasing an additional 33,558 shares during the period. Finally, Schonfeld Strategic Advisors LLC increased its holdings in Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock valued at $355,000 after purchasing an additional 52,500 shares during the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.